Health Care & Life Sciences » Pharmaceuticals | China Health Group Inc.

China Health Group Inc. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,838.70
7,495.80
25,282.70
23,650.00
67,445.20
70,600.60
Cost of Goods Sold (COGS) incl. D&A
12,503.60
1,780.80
6,142.70
15,404.40
22,425.20
27,107.40
Gross Income
6,335.10
5,715.00
19,139.90
8,245.50
45,020.00
43,493.10
SG&A Expense
26,282.90
11,681.70
15,102.70
4,785.80
4,630.80
10,816.40
EBIT
32,819.80
8,030.70
132.00
3,561.30
40,389.20
32,676.70
Unusual Expense
4,154.80
63,387.10
5,065.90
344.70
1,351.40
-
Non Operating Income/Expense
3,320.80
372.50
1,768.80
143.70
128.00
116.10
Interest Expense
5,468.30
214.00
1,007.80
934.70
87.60
74.60
Pretax Income
39,070.40
55,522.50
4,164.20
2,436.20
39,087.30
32,771.50
Income Tax
66.90
40.30
136.90
49.10
3,971.20
5,334.80
Consolidated Net Income
39,137.20
55,482.30
4,301.10
2,485.20
35,116.10
27,436.70
Net Income
39,148.60
55,522.50
4,135.90
2,485.20
35,116.10
27,436.70
Net Income After Extraordinaries
39,148.60
55,522.50
4,135.90
2,485.20
35,116.10
27,436.70
Net Income Available to Common
39,148.60
55,522.50
4,135.90
2,485.20
35,116.10
27,436.70
EPS (Basic)
0.07
0.15
0.00
0.00
0.04
0.03
Basic Shares Outstanding
545,042.20
381,154.00
915,272.00
915,484.00
992,772.00
992,772
EPS (Diluted)
0.05
0.12
0.00
0.00
0.04
0.03
Diluted Shares Outstanding
673,679.70
458,654.00
915,272.00
915,484.00
992,772.00
992,772
EBITDA
30,561.30
6,578.30
1,620.80
4,767.20
41,565.30
33,913.30
Other Operating Expense
12,872.10
2,064.00
3,905.20
101.70
-
-
Non-Operating Interest Income
51.70
7.60
8.60
10.50
9.20
53.30
Minority Interest Expense
11.40
40.30
165.30
-
-
-

About China Health Group

View Profile
Address
Building A2, Haitong Commercial Cntr
Beijing Beijing 100089
China
Employees -
Website http://www.chgi.net
Updated 07/08/2019
China Health Group, Inc. is an investment holding company, which provides drug discovery and development services. It engages in the research, development, and commercialization of pharmaceutical products. Its services include hospital management, hospital management service, mobile telemedicine service, therapy, service to rehabilitation, and medical tours service.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.